Recent NTRC News
Dose- and Effect-based Drug Combination Methods Merged into One Approach
Left: Dose-based synergy results from a decrease in dose to achieve the same effect, quantified with the CI [...]
NTRC Participates in Alpe d’HuZes 2020 to Raise Money for Cancer Research
NTRC thanks our sponsors for the cycling event Alpe d’HuZes. Special thanks to our shirt sponsors: Pivot Park, [...]
Expression of Cancer Immunotherapy Targets in Patient Material
Gene expression of TDO and IDO1 in ovarian cancer cell samples isolated from ascites. Expression [...]
OUR PREMIUM BENEFITS
Integration of cancer biology and big data analysis
Identification of patient selection markers
Side-by-side comparison with known anti cancer agents
Finding targeted and novel synergistic combinations
Science driven technology platforms
Short turnaround times
Oncolines™
